Loading chat...

ID H0528

Bill

Status

Enrolled

3/12/2026

Primary Sponsor

Health and Welfare Committee

Click for details

Origin

House of Representatives

2026 Regular Session

AI Summary

  • Health care providers and facilities cannot prohibit patients from providing their own blood or blood from a directed donor for transfusions, provided the blood is collected through a federally-compliant blood establishment

  • "Blood product" is defined to include whole blood, blood plasma, blood derivatives, blood platelets, and blood clotting agents

  • Exceptions apply when the transfusion would be detrimental to donor or patient, insufficient time exists to coordinate before a procedure, or the procedure involves emergency medical services

  • Health care providers and facilities receive immunity from liability for injuries, damages, or death resulting from patient-provided blood products, unless gross negligence contributed to the harm

  • Effective date of July 1, 2026, with the bill declared an emergency measure

Legislative Description

Adds to existing law to establish provisions regarding directed blood product transfusion.

DIRECTED BLOOD PRODUCT TRANSFUSION

Last Action

Delivered to Governor at 3:13 p.m. on March 12, 2026

3/12/2026

Committee Referrals

Health and Welfare2/18/2026
Health and Welfare1/27/2026

Full Bill Text

No bill text available